High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).

Sahajal Dhooria Inderpaul Singh SehgalRitesh AgarwalValliappan MuthuKuruswamy Thurai PrasadPooja DograUma DebiMandeep GargAmanjit BalNalini GuptaAshutosh Nath Aggarwal

Published in: The European respiratory journal (2023)

High-dose prednisolone was not superior to a lower dose in improving outcomes or the HRQoL in sarcoidosis and was associated with similar adverse effects.

Keyphrases

high dose
low dose
study protocol
stem cell transplantation
phase iii
open label
phase ii
clinical trial
randomized controlled trial
type diabetes
adipose tissue
skeletal muscle
weight loss